Literature DB >> 6478044

Capillary gas chromatographic/mass spectrometric analysis of abnormal metabolites in hypoglycin-treated rat urine.

D G Hine, K Tanaka.   

Abstract

Numerous abnormal metabolites were identified in large amounts in the urine of hypoglycin-treated rats using capillary gas chromatography/mass spectrometry-computer analysis. These metabolites are not detectable in significant amounts in normal rats' urine. Ten of them have not been previously associated with hypoglycin administration: these are several hydroxy compounds, including those from the valine and isoleucine pathways, 2-oxo-adipic acid, n-butyrylglycine and isovaleryl glucuronide. These results indicate that the pathways of isoleucine and valine metabolism are inhibited at their respective acyl-CoA dehydrogenation steps, as is the case for fatty acid, leucine and lysine metabolism, as previously shown. The mass spectra of the trimethylsilyl derivatives of cis, cis-4,7-decadiene-1,10-dioic, cis-4-decene-1,10-dioic, cis-4-octene-1,8-dioic acids, and (methylenecyclopropyl)acetylglycine, which were previously identified using nuclear magnetic resonance and oxidative cleavage or acid hydrolysis, are presented for the first time.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6478044     DOI: 10.1002/bms.1200110704

Source DB:  PubMed          Journal:  Biomed Mass Spectrom        ISSN: 0306-042X


  3 in total

1.  Metabolic consequences of methylenecyclopropylglycine poisoning in rats.

Authors:  K Melde; S Jackson; K Bartlett; H S Sherratt; S Ghisla
Journal:  Biochem J       Date:  1991-03-01       Impact factor: 3.857

2.  Organic aciduria in rats made resistant to hypoglycin toxicity by pretreatment with clofibrate.

Authors:  R K Veitch; H S Sherratt; K Bartlett
Journal:  Biochem J       Date:  1987-09-15       Impact factor: 3.857

3.  Altered plasma lysophosphatidylcholines and amides in non-obese and non-diabetic subjects with borderline-to-moderate hypertriglyceridemia: a case-control study.

Authors:  Sae Young Lee; Minjoo Kim; Saem Jung; Sang-Hyun Lee; Jong Ho Lee
Journal:  PLoS One       Date:  2015-04-09       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.